Exercise program for women with ovarian cancer before surgery
Official title: The Impact of Prehabilitation Exercise on Frailty and Treatment Outcomes in Ovarian Cancer Patients
Run by Nova Scotia Health Authority · NCT05364879 · Data updated 2026-11-12
This study tests whether a structured exercise program can help women with advanced ovarian cancer get stronger and recover better before their surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 108 (estimated) |
| Sponsor | Nova Scotia Health Authority Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Halifax, Nova Scotia) |
| Status | Recruiting |
| Started | January 3, 2023 |
| Main results expected | August 31, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | June 1, 2026 |
| Trial ID | NCT05364879 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18 or older with a confirmed diagnosis of stage III or IV ovarian cancer who are scheduled for cytoreductive surgery.
✕Probably not a fit
Patients who have already undergone surgery or have significant health issues that prevent safe participation in exercise will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on prehabilitation for women diagnosed with stage III or IV ovarian cancer, aiming to improve their physical condition before undergoing cytoreductive surgery. The intervention involves a structured exercise program designed to address frailty, which is common among these patients and can negatively impact surgical outcomes. Participants will engage in in-person and/or virtual exercise sessions, with a minimum of four weeks between enrollment and surgery to allow for adequate preparation. The goal is to enhance recovery and reduce complications associated with surgery.
Why it matters
Potential benefit: If successful, this approach could lead to improved surgical outcomes and recovery for women with ovarian cancer.
How similar studies have gone: While the specific approach of prehabilitation for ovarian cancer is novel, similar interventions in other cancer types have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Have a confirmed diagnosis of stage III or IV ovarian cancer * Scheduled to receive cytoreductive surgery as part of their treatment plan * Must have a minimum of 4-weeks between the time of study enrollment and scheduled surgery * Be able to attend in-person and/or virtual exercise sessions * Be fluent in English * Have oncologist approval Exclusion Criteria: * Have already completed surgery * Unstable cardiac or respiratory disease, injury or any other co-morbid disease that may make it unsafe for participants to exercise * Significant cognitive impairment (e.g., do not have the capacity to consent, unable to follow exercise instructions)
Where it's running
-
Nova Scotia Health
Halifax, Nova Scotia, Canada Recruiting
Study contacts
- Principal investigator: Scott Grandy, PhD — Nova Scotia Health
- Study coordinator: Scott Grandy, PhD
- Email: grandy@dal.ca
- Phone: 902-494-1145
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using auricular acupressure to improve health before lung surgery
This study is testing whether auricular acupressure can help improve the health and well-being of people aged 50 and older who are getting ready for major lung surgery.
-
Screening and assessment for older patients with ovarian cancer
This study is testing whether a special assessment and personalized exercise program can help older patients with ovarian cancer get better treatment options compared to standard care.
-
Improving resilience in gynaecological cancer patients before surgery
This study is testing whether a special program that includes exercise, mental support, and nutrition can help women with advanced ovarian and frail endometrial cancer feel better and recover faster before their surgery.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Postprandial drop and frailty in older adults having planned noncardiac surgery
This study tests whether a drop in blood pressure after meals and frailty predict low blood pressure after anesthesia starts in adults 65 and older undergoing planned noncardiac surgery.
-
Tramadol vs Morphine for Postoperative Pain After Laparoscopic Abdominal Surgery
This study tests whether tramadol can provide comparable pain relief to morphine after laparoscopic abdominal surgery when used as part of multimodal pain management.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.